U.S. flag An official website of the United States government

On Oct. 1, 2024, the FDA began implementing a reorganization impacting many parts of the agency. We are in the process of updating FDA.gov content to reflect these changes.

U.S. Food and Drug Administration
  1. Home
  2. Science & Research
  3. Science and Research Special Topics
  4. Advancing Regulatory Science
  5. Priority Area 9: Strengthening the Global Product Safety Net
  1. Advancing Regulatory Science

Priority Area 9: Strengthening the Global Product Safety Net

As FDA addresses the challenges of global supply chains, international trade, and foreign sourcing of foods, feeds, and medical products  it is relying on the support and commitment of a global community to ensure the safety of the food we eat and the medications we use. 

About 50% of the fresh fruits and 20% of fresh vegetables, as well as 80% of seafood consumed in America comes from abroad. More than 80% of the active pharmaceutical ingredients used to make medicines are imported. To ensure that the vast array of products Americans depend on are safe, FDA focus can no longer be solely domestic – it must be global. 

FDA has already undertaken efforts to support and collaborate with regulatory systems across the globe.  Examples include our foreign training programs on good clinical practice inspections and low and our involvement with the World Bank’s Global Food Safety Fund, a partnership of public and private organizations intended to boost food safety capacity around the world. 

Ensuring the safety of imported food and medicines takes all countries working together, including governments, industry, academia, and other stakeholders.

The following BAA-funded projects support efforts to build regulatory capacity through training, tools to strengthen surveillance systems in developing countries, and harnessing informatics to ensure the safety of FDA-regulated products.

  1. Mining Social Media for Public-Health Risks and Emerging TrendsExternal Link Disclaimer
  2. Creating a Global Regulatory Curriculum in Low and Middle Income Countries -- Phases 1 and 2External Link Disclaimer
  3. A Systematic Approach to Addressing Intentional Adulteration of FDA-regulated Food and Drug Products and Ingredients from the Global Supply ChainExternal Link Disclaimer
  4. Collaboration with FDA on a USP Spectral LibraryExternal Link Disclaimer
  5. Quality Engagement ForumExternal Link Disclaimer
  6. Informatics Master Data Domain Analysis for the Center of Drug Evaluation and ResearchExternal Link Disclaimer
  7. Community-based development of HTS standards for validating data and computation and encouraging interoperabilityExternal Link Disclaimer

 

Back to Top